HomePharma

Pharma

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Life Sciences Times - September 1, 2026

Pharma

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

Life Sciences Times - September 1, 2026

Pharma

Ascletis Doses First Participant in Global Phase 3 Program for Oral GLP-1 Drug ASC30

Life Sciences Times - August 31, 2026

Pharma

Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke

Life Sciences Times - August 31, 2026

Pharma

Lilly Reports One-Year Phase 3b Data for Taltz and Zepbound in Psoriatic Disease and Obesity

Life Sciences Times - August 31, 2026

Pharma

Novel technique to detect biomarker for cancer

Life Sciences Times - March 26, 2021 0

Pharma

3 common antiviral drugs potentially effective against Covid

Life Sciences Times - March 25, 2021 0

Pharma

New compound offers hope for anti-Covid drug

Life Sciences Times - March 25, 2021 0

Pharma

New Data Show Foreign Reference Drug Pricing Proposals Would Reduce the Development of New Innovative Medicines in California by 88%

Life Sciences Times - March 24, 2021 0

Pharma

Delix Therapeutics Names Mark Rus as Chief Executive Officer

Life Sciences Times - March 18, 2021 0

Pharma

FSD Pharma Enters into License Agreement to Develop Veterinary Drugs for the Treatment of Dogs and Cats

Life Sciences Times - March 17, 2021 0

Pharma

PerkinElmer Further Expands Capabilities in Biologics Drug Discovery

Life Sciences Times - March 17, 2021 0

Pharma

ViiV Healthcare presents positive proof-of-concept findings for a novel maturation inhibitor for the treatment of HIV

Life Sciences Times - March 9, 2021 0

Pharma

ReForm Biologics Announces the Issuance of Chinese Patent for Therapeutic Protein Formulations

Life Sciences Times - March 8, 2021 0

Pharma

IQVIA Collaborating with Janssen Research & Development on Their Investigational COVID-19 Vaccine Trials

Life Sciences Times - March 8, 2021 0

Pharma

Leading Sleep Medicine Expert Joins Apnimed Management Team

Life Sciences Times - March 4, 2021 0

Pharma

BeiGene Closes Collaboration with Novartis to Develop Anti-PD-1 Antibody Tislelizumab

Life Sciences Times - February 26, 2021 0

1...939495...99 Page 94 of 99

Flosonics Medical Partners With BARDA on AI-Enabled Trauma Technology for FloPatch

September 1, 2026

Tobias Janowitz Named Director of Feinstein Institutes’ Cancer Research Institute

September 1, 2026

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

September 1, 2026

Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia

September 1, 2026

Pharma

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

Ascletis Doses First Participant in Global Phase 3 Program for Oral GLP-1 Drug ASC30

Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke

Lilly Reports One-Year Phase 3b Data for Taltz and Zepbound in Psoriatic Disease and Obesity

Most Read

Flosonics Medical Partners With BARDA on AI-Enabled Trauma Technology for FloPatch

Tobias Janowitz Named Director of Feinstein Institutes’ Cancer Research Institute

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia

EDITOR PICKS

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia

Agenus Publishes Phase 1b Data on BOT+BAL in Metastatic Colorectal Cancer

THIS WEEK'S STORIES

Lilly to Acquire Merida Biosciences in Deal Worth Up to $2.875 Billion

Agenus Publishes Phase 1b Data on BOT+BAL in Metastatic Colorectal Cancer

Natera, Angiex Partner to Evaluate AGX101 Treatment Response Using Signatera

POPULAR CATEGORY

ABOUT US

FOLLOW US